Migraine - FOI Response Register

1. How many patients have been treated with the following drugs in the past 4 months?

•           Atogepant (Aquipta) – any disease                      0

•           Erenumab (Aimovig) - any disease                      3

•           Eptinezumab (Vyepti) – any disease                    0

•           Fremanezumab (Ajovy) - any disease                 3

•           Galcanezumab (Emgality) - any disease 0

•           Rimegepant (Vydura) – any disease                    0

•           Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested about Botulinum Toxin. This information is not recorded.

2. How many patients have you treated in the last 4 months for chronic migraine (15+ headache days per month) and episodic migraine (4-15 headache days per month) with the following drugs?

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested for Q2. This information is not recorded.

3. Does the trust actively initiate a treatment pause (usually at 12 months) of anti-CGRP (calcitonin gene-related peptide inhibitors) migraine treatment with the aim to re-start treatment if the patient continues to fit the criteria (Yes/No)?

NHS Shetland does not initiate this medication, this would be done by NHS Grampian.